Cannabis has never been more accessible. With its popularity skyrocketing, many professional athletes have been outspoken regarding their use of marijuana.
Megan Rapinoe, an Olympic gold medalist, two-time Women's World Cup soccer champion and 2019 FIFA Women's World Player of the Year told Benzinga earlier that she ventured into cannabis in a search of a “healthier, more natural option for pain management, sleep aid, relaxation while flying, and general recovery.”
However, it seems that many of her colleagues have been penalized for cannabis use, including U.S. sprinter Sha’Carri Richardson who made international headlines in 2021 after being suspended for one month after testing positive for THC.
To tackle the growing issue, the U.S. congressional lawmakers have included a novel section alongside myriad other marijuana provisions in appropriations legislation covering the fiscal year 2023 financing for several federal agencies, reported Marijuana Moment.
House Appropriations Committee leaders’ move is aimed to push international officials to “change how cannabis is treated” as it seeks to put an end to the practice of suspending athletes from competition after being tested positive for cannabis.
The recently released spending bills and attached reports are related to spending packages for the Financial Services and General Government (FSGG), as well as Departments of Labor and Health and Human Services (HHS) and Education.
Now, the committee is urging the U.S. Anti-Doping Agency (USADA), which manages the anti-doping program for all U.S. Olympic and Paralympic Committee-recognized sports, to take action.
“The Committee encourages USADA to support additional research on the effects of cannabis on athletic performance, including whether marijuana use during the in-competition period delivers performance-enhancing effects, and to engage in efforts to change how cannabis is treated under the World Anti-Doping Code and World Anti-Doping Agency Prohibited List,” the committee's report said.
Benzinga photo. Source: Image from Shutterstock
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.